The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.

Learn about the companies that are manufacturing vaccines and what you should know before investing in vaccine stocks.

Dimensions (mm) 269.70 x 363.00 x 21.95 233.70 x 356.80 x 15.90 Weight (kg) 2.6 1.6 ...

Dimensions (mm) 250.90 x 350.60 x 11.10 254.30 x 357.70 x 11.90 ...

Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...

According to Shannon Sharpe, Travis Kelce is barbecue, and Rob Gronkowski is sushi. When the legendary tight end was ...

Classic Mercedes design meets the 2025 S63 in a visual mashup that draws attention to two very different eras of the same ...

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

The Trump administration’s dramatic reworking of U.S. public-health agencies’ approach to vaccines is creating a difficult and unpredictable situation for drugmakers.

A new comprehensive study of billions of mRNA vaccine shots confirm that they are safe and effective and that serious side effects are rare.

Picking a good dividend stock for your portfolio can be challenging, especially when there are many attractive high-yielding ...

MRNA surged 14%, dwarfing the 2% gains of MRK and PFE, driven by an FDA flu vaccine endorsement and a blowout Q1 revenue beat. Despite MRNA's 130% YTD surge, Wall Street's consensus target of $43 sits ...